Rigel Pharmaceuticals, Inc. RIGL
$32.35
▲ +2.40% 24H
About
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. It operates as a clinical-stage biopharmaceutical firm, specializing in targeted drugs within the therapeutic a…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees162
TickerRIGL
Statistics
Market Cap$597.9M
Revenue (TTM)$294.3M
Net Income$367.0M
Net Margin124.7%
EPS$19.48
P/E1.66
P/S1.98
P/B1.48
EV/EBITDA3.88
ROE174.1%
Dividend Yield—
Price$32.35
Data: Twelve Data · Revenue = mcap / P/S